Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastatic Sarcoma

NCT05952128 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: Fluzoparib+ Dalpiciclib

Sponsor

Sun Yat-sen University

Collaborators

[object Object]